Terms ending in 2034
Every in-force patent on Abraxis Bioscience, LLC's record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,511,046 | Methods of Treating Pancreatic Cancer In force · High confidence | Abraxis Bioscience, LLC | In force | High confidence | |
| US 10,744,110 | Methods of Treating Lung Cancer In force · High confidence | Abraxis Bioscience, LLC | In force | High confidence | |
| US 9,962,373 | Methods of Treating Bladder Cancer In force · High confidence | Abraxis Bioscience, LLC | In force | High confidence | |
| US 10,413,531 | Methods of Treating Bladder Cancer In force · High confidence | Abraxis Bioscience, LLC | In force | High confidence |
4 of 4 patents shown. Soonest term end first, then patent number.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.